106 related articles for article (PubMed ID: 9823432)
1. Megestrol acetate antagonizes cisplatin cytotoxicity.
Pu YS; Cheng AL; Chen J; Guan JY; Lu SH; Lai MK; Hsieh CY
Anticancer Drugs; 1998 Sep; 9(8):733-8. PubMed ID: 9823432
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
Pu YS; Hour TC; Chen J; Huang CY; Guan JY; Lu SH
Urology; 2002 Aug; 60(2):346-50. PubMed ID: 12137851
[TBL] [Abstract][Full Text] [Related]
3. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells.
Pu YS; Chen J; Huang CY; Guan JY; Lu SH; Hour TC
J Urol; 2001 Jun; 165(6 Pt 1):2082-5. PubMed ID: 11371932
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways.
Masters JR; Thomas R; Hall AG; Hogarth L; Matheson EC; Cattan AR; Lohrer H
Eur J Cancer; 1996 Jun; 32A(7):1248-53. PubMed ID: 8758261
[TBL] [Abstract][Full Text] [Related]
6. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
Hofs HP; Wagener TD; de Valk-Bakker V; van Rennes H; Doesburg WH; Ottenheijm HC; de Grip WJ
Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin.
Kasahara K; Fujiwara Y; Nishio K; Ohmori T; Sugimoto Y; Komiya K; Matsuda T; Saijo N
Cancer Res; 1991 Jun; 51(12):3237-42. PubMed ID: 1645616
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
9. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
10. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
Mistry P; Kelland LR; Abel G; Sidhar S; Harrap KR
Br J Cancer; 1991 Aug; 64(2):215-20. PubMed ID: 1892748
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line.
Yasuno T; Matsumura T; Shikata T; Inazawa J; Sakabe T; Tsuchida S; Takahata T; Miyairi S; Naganuma A; Sawada T
Anticancer Res; 1999; 19(5B):4049-57. PubMed ID: 10628353
[TBL] [Abstract][Full Text] [Related]
12. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.
Rhodes T; Twentyman PR
Br J Cancer; 1992 May; 65(5):684-90. PubMed ID: 1316774
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cisplatin sensitivity and accumulation by interferon alpha-2A in human squamous carcinoma cell lines.
Gupta V; Jani JP; Emerson EO; Xu BH; Scalamogna D; Xia H; Katoh A; Zaren HA; Singh SV
Int J Cancer; 1995 Nov; 63(3):419-22. PubMed ID: 7591242
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
15. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
Mellish KJ; Kelland LR; Harrap KR
Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
[TBL] [Abstract][Full Text] [Related]
16. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
Lai SL; Hwang J; Perng RP; Whang-Peng J
Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
Ripple M; Mulcahy RT; Wilding G
J Urol; 1993 Jul; 150(1):209-14. PubMed ID: 8510259
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic study of potentiation of chemotherapy by a haloenol lactone derivative in vitro.
Wang W; Xia CQ; Liu N; Gan LS; Zheng J
Cancer Chemother Pharmacol; 2008 Jun; 62(1):117-22. PubMed ID: 17899085
[TBL] [Abstract][Full Text] [Related]
20. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
Cole SP; Downes HF; Mirski SE; Clements DJ
Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
